These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 18776046

  • 1. Effects of cholecystokinin-58 on type 1 cholecystokinin receptor function and regulation.
    Wu SV, Harikumar KG, Burgess RJ, Reeve JR, Miller LJ.
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G641-7. PubMed ID: 18776046
    [Abstract] [Full Text] [Related]

  • 2. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 3. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
    Dunlop J, Zhang Y, Evans N.
    Peptides; 1997 Jan 31; 18(6):865-8. PubMed ID: 9285936
    [Abstract] [Full Text] [Related]

  • 4. Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A.
    Tarasova NI, Stauber RH, Choi JK, Hudson EA, Czerwinski G, Miller JL, Pavlakis GN, Michejda CJ, Wank SA.
    J Biol Chem; 1997 Jun 06; 272(23):14817-24. PubMed ID: 9169450
    [Abstract] [Full Text] [Related]

  • 5. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.
    Harikumar KG, Dong M, Cheng Z, Pinon DI, Lybrand TP, Miller LJ.
    Biochemistry; 2006 Dec 12; 45(49):14706-16. PubMed ID: 17144663
    [Abstract] [Full Text] [Related]

  • 6. A segment of five amino acids in the second extracellular loop of the cholecystokinin-B receptor is essential for selectivity of the peptide agonist gastrin.
    Silvente-Poirot S, Wank SA.
    J Biol Chem; 1996 Jun 21; 271(25):14698-706. PubMed ID: 8663021
    [Abstract] [Full Text] [Related]

  • 7. Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
    Laverman P, Béhé M, Oyen WJ, Willems PH, Corstens FH, Behr TM, Boerman OC.
    Bioconjug Chem; 2004 Jun 21; 15(3):561-8. PubMed ID: 15149184
    [Abstract] [Full Text] [Related]

  • 8. Regulation of lateral mobility and cellular trafficking of the CCK receptor by a partial agonist.
    Roettger BF, Pinon DI, Burghardt TP, Miller LJ.
    Am J Physiol; 1999 Mar 21; 276(3):C539-47. PubMed ID: 10069980
    [Abstract] [Full Text] [Related]

  • 9. Distinct molecular mechanisms for agonist peptide binding to types A and B cholecystokinin receptors demonstrated using fluorescence spectroscopy.
    Harikumar KG, Clain J, Pinon DI, Dong M, Miller LJ.
    J Biol Chem; 2005 Jan 14; 280(2):1044-50. PubMed ID: 15520004
    [Abstract] [Full Text] [Related]

  • 10. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA, Sharp CM, Sutliff VE, Martinez J, Jensen RT, Gardner JD.
    Biochim Biophys Acta; 1989 Feb 09; 1010(2):145-50. PubMed ID: 2463851
    [Abstract] [Full Text] [Related]

  • 11. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Jul 09; 124(5):935-45. PubMed ID: 9692779
    [Abstract] [Full Text] [Related]

  • 12. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S, Hadjiivanova C, Escrieut C, Dufresne M, Martinez J, Vaysse N, Fourmy D.
    Eur J Biochem; 1993 Mar 01; 212(2):529-38. PubMed ID: 8444190
    [Abstract] [Full Text] [Related]

  • 13. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May 01; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 14. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
    Harikumar KG, Pinon DI, Wessels WS, Dawson ES, Lybrand TP, Prendergast FG, Miller LJ.
    Mol Pharmacol; 2004 Jan 01; 65(1):28-35. PubMed ID: 14722234
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP, Zhou W, Longnecker DS, Bell RH.
    Oncol Res; 1994 Jan 01; 6(9):411-7. PubMed ID: 7703527
    [Abstract] [Full Text] [Related]

  • 16. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
    Dong M, Lam PC, Pinon DI, Abagyan R, Miller LJ.
    Biochemistry; 2009 Jun 16; 48(23):5303-12. PubMed ID: 19441839
    [Abstract] [Full Text] [Related]

  • 17. Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.
    Gigoux V, Escrieut C, Fehrentz JA, Poirot S, Maigret B, Moroder L, Gully D, Martinez J, Vaysse N, Fourmy D.
    J Biol Chem; 1999 Jul 16; 274(29):20457-64. PubMed ID: 10400673
    [Abstract] [Full Text] [Related]

  • 18. Ligand-induced internalization of the type 1 cholecystokinin receptor independent of recognized signaling activity.
    Cawston EE, Harikumar KG, Miller LJ.
    Am J Physiol Cell Physiol; 2012 Feb 01; 302(3):C615-27. PubMed ID: 22049215
    [Abstract] [Full Text] [Related]

  • 19. Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor.
    Pearson RK, Miller LJ.
    J Biol Chem; 1987 Jan 15; 262(2):869-76. PubMed ID: 3805011
    [Abstract] [Full Text] [Related]

  • 20. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG, Dhôtel H, Ducos B, Durieux C, Goudreau N, Bado A, Garbay C, Roques BP.
    J Med Chem; 1997 Feb 28; 40(5):647-58. PubMed ID: 9057851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.